Skip to main content
Premium Trial:

Request an Annual Quote

Bayer, Broad Expand Collaboration to Include Cardiovascular Genomics

NEW YORK (GenomeWeb) – Bayer HealthCare today announced it has expanded a drug development collaboration with the Broad Institute to include cardiovascular genomics. 

As part of the expanded deal, Bayer and the Broad will collaborate on genetic discovery, target identification, and drug discovery activities. A joint steering committee and joint research committee will oversee research progress and direction, Bayer said. Financial and other terms of the deal were not disclosed. 

The deal expands an agreement reached by the partners in September 2013 to discover and develop therapeutic agents targeting cancer genome alterations.

Bayer said that while lifestyle factors, such as smoking, diet, and exercise, are the main culprits behind heart disease, genetic factors can influence the predisposition to cardiovascular disease, the age of onset, and severity.

The Scan

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.

Adenine Base Editor Targets SCID Mutation in New Study

Researchers from the University of California, Los Angeles, report in Cell that adenine base editing was able to produce functional T lymphocytes in a model of severe combined immune deficiency.

Researchers Find Gene Affecting Alkaline Sensitivity in Plants

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.